AIkido Pharma (AIKI) Competitors $1.57 -0.06 (-3.68%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends AIKI vs. XELB, ONMD, BIAF, FOXO, ISPC, DKDCA, FNJN, REFR, ACTG, and IQVShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Xcel Brands (XELB), OneMedNet (ONMD), bioAffinity Technologies (BIAF), FOXO Technologies (FOXO), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), Finjan (FNJN), Research Frontiers (REFR), Acacia Research (ACTG), and IQVIA (IQV). AIkido Pharma vs. Xcel Brands OneMedNet bioAffinity Technologies FOXO Technologies iSpecimen Data Knights Acquisition Finjan Research Frontiers Acacia Research IQVIA Xcel Brands (NASDAQ:XELB) and AIkido Pharma (NASDAQ:AIKI) are both small-cap retail/wholesale companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Which has preferable earnings and valuation, XELB or AIKI? AIkido Pharma has lower revenue, but higher earnings than Xcel Brands. Xcel Brands is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXcel Brands$17.75M0.93-$21.05M-$0.90-0.78AIkido Pharma$10K861.15-$7.17M-$3.88-0.40 Is XELB or AIKI more profitable? AIkido Pharma has a net margin of 0.00% compared to Xcel Brands' net margin of -179.30%. AIkido Pharma's return on equity of -18.21% beat Xcel Brands' return on equity.Company Net Margins Return on Equity Return on Assets Xcel Brands-179.30% -20.74% -14.31% AIkido Pharma N/A -18.21%-16.94% Which has more risk & volatility, XELB or AIKI? Xcel Brands has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Does the media refer more to XELB or AIKI? In the previous week, Xcel Brands had 1 more articles in the media than AIkido Pharma. MarketBeat recorded 1 mentions for Xcel Brands and 0 mentions for AIkido Pharma. Xcel Brands' average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score. Company Overall Sentiment Xcel Brands Neutral AIkido Pharma Neutral Does the MarketBeat Community believe in XELB or AIKI? Xcel Brands received 133 more outperform votes than AIkido Pharma when rated by MarketBeat users. However, 63.92% of users gave AIkido Pharma an outperform vote while only 47.56% of users gave Xcel Brands an outperform vote. CompanyUnderperformOutperformXcel BrandsOutperform Votes23447.56% Underperform Votes25852.44% AIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% Do insiders & institutionals believe in XELB or AIKI? 18.6% of Xcel Brands shares are held by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are held by institutional investors. 45.2% of Xcel Brands shares are held by company insiders. Comparatively, 8.6% of AIkido Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryXcel Brands beats AIkido Pharma on 8 of the 14 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.61M$4.39B$5.08B$8.80BDividend YieldN/A1.65%5.02%4.07%P/E Ratio-0.4036.7391.2813.60Price / Sales861.1558.531,226.2187.40Price / CashN/A23.4239.4536.27Price / Book0.083.346.906.33Net Income-$7.17M$139.66M$118.83M$225.93M7 Day Performance0.64%-1.99%-1.92%-0.96%1 Month Performance-13.26%15.17%-3.75%1.06%1 Year Performance-22.47%34.92%31.37%26.59% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$1.57-3.7%N/A-18.5%$8.61M$10,000.00-0.404Gap DownXELBXcel Brands0.6192 of 5 stars$0.70-0.7%N/A-28.0%$16.51M$17.75M0.0080ONMDOneMedNetN/A$0.86+2.4%N/A-82.3%$24.23M$1.02M0.002BIAFbioAffinity Technologies2.4464 of 5 stars$1.22-3.9%$6.00+391.8%-11.8%$19.02M$2.53M-1.5510Gap UpFOXOFOXO TechnologiesN/A$0.62-6.4%N/A+117.4%$8.42M$140,000.000.003News CoverageGap UpISPCiSpecimen0.0815 of 5 stars$4.69+1.7%N/A+694.8%$4.50M$9.93M0.0060DKDCAData Knights AcquisitionN/A$0.84-1.2%N/A-82.1%$4.35MN/A-4.422FNJNFinjanN/A$1.54flatN/AN/A$42.66M$13.15M-2.5710REFRResearch Frontiers0.0521 of 5 stars$1.96+0.7%N/A+91.2%$65.84M$910,000.00-65.006Positive NewsACTGAcacia Research2.9006 of 5 stars$4.51+1.3%$7.00+55.2%+18.7%$439.14M$125.10M8.40290IQVIQVIA4.9855 of 5 stars$194.97+0.3%$256.50+31.6%-5.3%$35.39B$14.98B25.5187,000Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies Xcel Brands Alternatives OneMedNet Alternatives bioAffinity Technologies Alternatives FOXO Technologies Alternatives iSpecimen Alternatives Data Knights Acquisition Alternatives Finjan Alternatives Research Frontiers Alternatives Acacia Research Alternatives IQVIA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIKI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
